Article

Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children

Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
British Journal of Haematology (Impact Factor: 4.96). 10/2005; 130(5):781-7. DOI: 10.1111/j.1365-2141.2005.05670.x
Source: PubMed

ABSTRACT Febrile non-haemolytic or allergic reactions occur in 0.1-30% of transfusions; physicians often premedicate patients with acetaminophen or diphenhydramine to prevent these reactions. The effectiveness of this practice has not been demonstrated. In this retrospective review of all transfusions at our institution during 2002, 385 patients received 7900 evaluable leucoreduced, irradiated blood products (4280 single-donor apheresis platelets and 3620 packed red blood cells). Febrile reactions occurred in 0.95% of 4108 transfusions with, and 0.53% of 3792 transfusions without, acetaminophen premedication. Allergic reactions occurred in 0.90% of 4315 transfusions with, and 0.56% of 3585 transfusions without, diphenhydramine premedication. In a multivariate analysis that adjusted for age, patient category, transfusion location, product, transfusion history, and reaction history, premedication with acetaminophen was associated with a statistically non-significant increase in the odds of a febrile reaction (odds ratio 1.74; 95% confidence interval 0.71-4.23; P = 0.22), and diphenhydramine with a non-significant increase in allergic reactions (odds ratio 1.74; 95% confidence interval 0.99-3.06; P = 0.054). Reactions occurred in only 1.3% of the 518 transfusions to patients with a history of two or more prior reactions. Febrile and allergic transfusion reactions were rare in paediatric patients transfused with leucoreduced, irradiated blood products, whether premedication was used or not.

Download full-text

Full-text

Available from: Scott C Howard, Nov 12, 2014
0 Followers
 · 
180 Views
  • Source
    • "There are several studies of prevention/prophylaxis, including one large RCT (Patterson et al, 2000; Wang et al, 2002; Sanders et al, 2005; Kennedy et al, 2008). None showed that premedication with an antihistamine (diphenhydramine ), as widely used in the United States, was effective whether or not patients had experienced a previous reaction. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although acute non-haemolytic febrile or allergic reactions (ATRs) are a common complication of transfusion and often result in little or no morbidity, prompt recognition and management are essential. The serious hazards of transfusion haemovigilance organisation (SHOT) receives 30-40 reports of anaphylactic reactions each year. Other serious complications of transfusion, such as acute haemolysis, bacterial contamination, transfusion-related acute lung injury (TRALI) or transfusion-associated circulatory overload (TACO) may present with similar clinical features to ATR. This guideline describes the approach to a patient developing adverse symptoms and signs related to transfusion, including initial recognition, establishing a likely cause, treatment, investigations, planning future transfusion and reporting within the hospital and to haemovigilance organisations. Key recommendations are that adrenaline should be used as first line treatment of anaphylaxis, and that transfusions should only be carried out where patients can be directly observed and where staff are trained in manging complications of transfusion, particularly anaphylaxis. Management of ATRs is not dependent on classification but should be guided by symptoms and signs. Patients who have experienced an anaphylactic reaction should be discussed with an allergist or immunologist, in keeping with UK resuscitation council guidelines.
    British Journal of Haematology 08/2012; 159(2):143-53. DOI:10.1111/bjh.12017 · 4.96 Impact Factor
  • Asian Journal of Transfusion Science 01/2014; 8(2):144-145. DOI:10.4103/0973-6247.137462
  • Geriatrics 03/1974; 29(2):85-93. · 1.35 Impact Factor
Show more